Detalhe da pesquisa
1.
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer.
Immunity
; 56(11): 2602-2620.e10, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967532
2.
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
Immunity
; 54(1): 164-175.e6, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33382973
3.
Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control.
PLoS Pathog
; 20(1): e1011982, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271469
4.
Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles.
PLoS Pathog
; 19(10): e1011725, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883584
5.
Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions.
Immunity
; 44(1): 167-178, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26795249
6.
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
Proc Natl Acad Sci U S A
; 119(8)2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131898
7.
Monitoring of hepatitis E virus in wastewater can identify clinically relevant variants.
Liver Int
; 44(3): 637-643, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291853
8.
A systematic comparison reveals dynamic differences in early adaptive immune responses of acute-resolving versus chronic HBV replication.
J Med Virol
; 95(3): e28670, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916726
9.
Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro.
BMC Biol
; 20(1): 264, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36447206
10.
Prophylactic and therapeutic HBV vaccination by an HBs-expressing cytomegalovirus vector lacking an interferon antagonist in mice.
Eur J Immunol
; 51(2): 393-407, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029793
11.
Generation of HBsAg-reactive T- and B-cells following HBV vaccination in serological non-responders under hemodialysis treatment.
Eur J Immunol
; 51(5): 1278-1281, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459347
12.
Production of HIV-1 Env-specific antibodies mediating innate immune functions depends on cognate IL-21- secreting CD4+ T cells.
J Virol
; 95(8)2021 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504598
13.
Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.
J Virol
; 95(24): e0003421, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34550772
14.
Qualitative Differences Between the IFNα subtypes and IFNß Influence Chronic Mucosal HIV-1 Pathogenesis.
PLoS Pathog
; 16(10): e1008986, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064743
15.
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.
PLoS Pathog
; 16(3): e1008340, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32226027
16.
Functional Comparison of Interferon-α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon-α and Interferon-γ Signaling.
Hepatology
; 73(2): 486-502, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333814
17.
Comparable Environmental Stability and Disinfection Profiles of the Currently Circulating SARS-CoV-2 Variants of Concern B.1.1.7 and B.1.351.
J Infect Dis
; 224(3): 420-424, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993274
18.
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
Emerg Infect Dis
; 27(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33058753
19.
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.
Pharmacogenet Genomics
; 31(8): 165-171, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001841
20.
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy.
Gastroenterology
; 158(8): 2180-2194, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147484